Literature DB >> 22890762

Macrolides and β-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism.

Elisa Ramos-Sevillano1, Cinthya Rodríguez-Sosa, Roberto Díez-Martínez, María-José Giménez, Eduardo Olmedillas, Pedro García, Ernesto García, Lorenzo Aguilar, Jose Yuste.   

Abstract

The emergence of Streptococcus pneumoniae strains displaying high levels of multidrug resistance is of great concern worldwide and a serious threat for the outcome of the infection. Modifications of the bacterial envelope by antibiotics may assist the recognition and clearance of the pathogen by the host immune system. Recognition of S. pneumoniae resistant strains by the complement component C3b was increased in the presence of specific anti-pneumococcal antibodies and subinhibitory concentrations of different macrolides and β-lactam antibiotics for all the strains investigated. However, C3b levels were unchanged in the presence of serum containing specific antibodies and sub-MICs of levofloxacin. To investigate whether LytA, the main cell wall hydrolase of S. pneumoniae, might be involved in this process, lytA-deficient mutants were constructed. In the presence of antibiotics, loss of LytA was not associated with enhanced C3b deposition on the pneumococcal surface, which confirms the importance of LytA in this interaction. The results of this study offer new insights into the development of novel therapeutic strategies using certain antibiotics by increasing the efficacy of the host immune response to efficiently recognize pneumococcal resistant strains.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890762      PMCID: PMC3486588          DOI: 10.1128/AAC.01470-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

Review 1.  Complement. Second of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

2.  Enhanced decrease of blood colony counts by specific anti-pneumococcal antibodies in the presence of sub-inhibitory concentrations of amoxicillin.

Authors:  J Yuste; M J Giménez; I Jado; A Fenoll; L Aguilar; J Casal
Journal:  J Antimicrob Chemother       Date:  2001-10       Impact factor: 5.790

3.  Combined effect of specific antibodies (as serotherapy or preimmunization) and amoxicillin doses in treatment of Streptococcus pneumoniae sepsis in a mouse model.

Authors:  J Yuste; A Fenoll; J Casal; M J Giménez; L Aguilar
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.

Authors:  Jeremy S Brown; Tracy Hussell; Sarah M Gilliland; David W Holden; James C Paton; Michael R Ehrenstein; Mark J Walport; Marina Botto
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

5.  Minimization of bacterial size allows for complement evasion and is overcome by the agglutinating effect of antibody.

Authors:  Ankur B Dalia; Jeffrey N Weiser
Journal:  Cell Host Microbe       Date:  2011-11-17       Impact factor: 21.023

Review 6.  The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria.

Authors:  A Tomasz
Journal:  Annu Rev Microbiol       Date:  1979       Impact factor: 15.500

7.  Beta-lactam modification of the bacteraemic profile and its relationship with mortality in a pneumococcal mouse sepsis model.

Authors:  J Yuste; I Jado; A Fenoll; L Aguilar; M J Giménez; J Casal
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

8.  Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model.

Authors:  J Casal; L Aguilar; I Jado; J Yuste; M J Giménez; J Prieto; A Fenoll
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

9.  Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.

Authors:  Julien M Buyck; Patrick Plésiat; H Traore; F Vanderbist; Paul M Tulkens; Françoise Van Bambeke
Journal:  Clin Infect Dis       Date:  2012-05-09       Impact factor: 9.079

Review 10.  The challenge of emerging and re-emerging infectious diseases.

Authors:  David M Morens; Gregory K Folkers; Anthony S Fauci
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

View more
  9 in total

1.  Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.

Authors:  Elisa Ramos-Sevillano; Ana Urzainqui; Susana Campuzano; Miriam Moscoso; Fernando González-Camacho; Mirian Domenech; Santiago Rodríguez de Córdoba; Francisco Sánchez-Madrid; Jeremy S Brown; Ernesto García; Jose Yuste
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

2.  Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract.

Authors:  Bruno Corsini; Roberto Díez-Martínez; Leire Aguinagalde; Fernando González-Camacho; Esther García-Fernández; Patricia Letrado; Pedro García; Jose Yuste
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

3.  Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers.

Authors:  Steven M Szczepanek; Sean Roberts; Kara Rogers; Christina Cotte; Alexander J Adami; Sonali J Bracken; Sharon Salmon; Eric R Secor; Roger S Thrall; Biree Andemariam; Dennis W Metzger
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

Review 4.  Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.

Authors:  Greiciely O Andre; Thiago R Converso; Walter R Politano; Lucio F C Ferraz; Marcelo L Ribeiro; Luciana C C Leite; Michelle Darrieux
Journal:  Front Microbiol       Date:  2017-02-20       Impact factor: 5.640

Review 5.  Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract.

Authors:  Mirian Domenech; Julio Sempere; Sara de Miguel; Jose Yuste
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

6.  Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases.

Authors:  Patricia Richi; Jose Yuste; Teresa Navío; Laura González-Hombrado; Marina Salido; Israel Thuissard-Vasallo; Ana Jiménez-Díaz; Jesús Llorente; Laura Cebrián; Leticia Lojo; Martina Steiner; Tatiana Cobo; María Dolores Martín; Marta García-Castro; Patricia Castro; Santiago Muñoz-Fernández
Journal:  Vaccines (Basel)       Date:  2021-02-28

7.  CSF Levels of Elongation Factor Tu Is Associated With Increased Mortality in Malawian Adults With Streptococcus pneumoniae Meningitis.

Authors:  Emma C Wall; Philip Brownridge; Gavin Laing; Vanessa S Terra; Veronica Mlozowa; Brigitte Denis; Mulinda Nyirenda; Theresa Allain; Elisa Ramos-Sevillano; Enitan Carrol; Andrea Collins; Stephen B Gordon; David G Lalloo; Brendan Wren; Robert Beynon; Robert S Heyderman; Jeremy S Brown
Journal:  Front Cell Infect Microbiol       Date:  2020-12-11       Impact factor: 5.293

8.  Antibiotic Combined with Epitope-Specific Monoclonal Antibody Cocktail Protects Mice Against Bacteremia and Acute Pneumonia from Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  LianLi Duan; Jinyong Zhang; Zhifu Chen; Qiang Gou; Qingshan Xiong; Yue Yuan; Haiming Jing; Jiang Zhu; Li Ni; Yuling Zheng; Zhiyong Liu; Xiaokai Zhang; Hao Zeng; Quanming Zou; Zhuo Zhao
Journal:  J Inflamm Res       Date:  2021-08-30

9.  Detection of lytA, pspC, and rrgA genes in Streptococcus pneumoniae isolated from healthy children.

Authors:  Tahereh Gholamhosseini-Moghaddam; Mehrnaz Rad; Seyed Fazlollah Mousavi; Kiarash Ghazvini
Journal:  Iran J Microbiol       Date:  2015-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.